McKesson Corporation
MCK Healthcare Medical Distribution
McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.
Follow MCK
McKesson Corporation (MCK) Free cash flow margin
McKesson Corporation's free cash flow margin over the twelve months to 30 June 2026 was 1.50%, up 0.2 percentage points from fiscal 2026 (1.34%). Over the past ten years it has ranged from 1.17% (fiscal 2024) to 2.11% (fiscal 2017); the current reading is higher than 17% of that period. That is above the Medical Distribution industry median of 0.00% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2026 | 1.34% | (0.12) |
| FY2025 | 1.46% | 0.29 |
| FY2024 | 1.17% | (0.49) |
| FY2023 | 1.66% | 0.18 |
| FY2022 | 1.48% | (0.16) |
| FY2021 | 1.64% | (0.03) |
| FY2020 | 1.67% | 0.05 |
| FY2019 | 1.62% | (0.19) |
| FY2018 | 1.81% | (0.30) |
| FY2017 | 2.11% | 0.54 |
Against its own ten years
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| HSIC Henry Schein, Inc. compare | 4.18% |
| CAH Cardinal Health, Inc. compare | 1.79% |
| MCK McKesson Corporation | 1.50% |
| COR Cencora, Inc. compare | 1.23% |
| AHG Akso Health Group Sponsored ADR compare | 0.00% |
| HKPD Cellyan Biotechnology Co., Ltd compare | 0.00% |
| ACH Accendra Health, Inc. compare | −7.97% |
| COSM Cosmos Health Inc. compare | −16.9% |
| FOCL FocalTherics compare | −24.6% |
| Medical Distribution industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on MCK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement